Juno Therapeutics (NASDAQ: JUNO) recently received a number of ratings updates from brokerages and research firms:
Shares of Juno Therapeutics Inc (NASDAQ:JUNO) opened at 22.56 on Friday. Juno Therapeutics Inc has a one year low of $19.41 and a one year high of $57.82. The stock’s market capitalization is $2.31 billion. The stock has a 50 day moving average price of $27.75 and a 200 day moving average price of $33.02.
Juno Therapeutics (NASDAQ:JUNO) last posted its quarterly earnings data on Wednesday, November 9th. The biopharmaceutical company reported ($0.57) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.52) by $0.05. The company earned $20.80 million during the quarter, compared to the consensus estimate of $10.98 million. During the same quarter last year, the firm posted ($0.26) EPS. The company’s revenue was up 1200.0% compared to the same quarter last year. Equities analysts forecast that Juno Therapeutics Inc will post ($2.54) earnings per share for the current year.